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Abstract
Nitric Oxide (NO) is a diffusible second messenger that modulates ion channels, intrinsic excitability and mediates synaptic
plasticity. In light of its activity-dependent generation in the principal neurons of the medial nucleus of the trapezoid body
(MNTB), we have investigated its potential modulatory effects on native voltage-gated calcium channels (CaV) within this
nucleus. Whole-cell patch recordings were made from brain slices from P13–15 CBA mice. Slices were incubated with the
inhibitor of neuronal nitric oxide synthase (nNOS) 7-nitroindazole (10 mM) and pharmacological blockers used to isolate Ca
2+
current subtypes. Unpaired observations in the presence and absence of the NO-donors sodium nitroprusside (SNP,
100 mM) or Diethyl-ammonium-nonoate (DEA, 100 mM) were made to elucidate NO-dependent modulation of the
expressed CaV subtypes. A differential effect of NO on the calcium channel subtypes was observed: CaV1 and CaV2.1 (L+R-
and P/Q+R-type) conductances were potentiated, whereas N+R-type (CaV2.2) and R-type (CaV2.3) current amplitudes were
unaffected. L+R-type currents increased from 0.3660.04 nA to 0.6460.11 nA and P/Q+R-type from 0.5560.09 nA to
0.9460.05 nA, thereby changing the balance and relative contribution of each subtype to the whole cell calcium current. In
addition, N+R-type half-activation voltage was left shifted following NO exposure. NO-dependent modulation of P/Q+R and
N+R-type, but not L+R-type, channels was removed by inhibition of soluble guanylyl cyclase (sGC) activity. This data
demonstrates a differential effect of NO signalling on voltage-gated calcium entry, by distinct NO-dependent pathways.
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Introduction
Nitric oxide is an important signalling molecule and volume
transmitter with a functional role in both central and peripheral
systems [1,2,3,4]. The modulation of ion channels is one of several
mechanisms mediating the physiological functions of NO,
including relaxation of vascular smooth muscle [5,6], neurotrans-
mission, synaptic plasticity and neurodegenerative processes
[1,4,7,8]. Ion channel modulation by NO can be mediated
directly by S-nitrosylation [9,10] or indirectly through second
messengers involving the activation of soluble guanylyl cyclase
(sGC) to generate cyclic guanosine monophosphate (cGMP)
[8,11]. The presence of nNOS and sGC in the auditory brainstem
(including the MNTB) and its functional role in modulating
potassium channels and excitability within the auditory brainstem
has been documented [4,12].
Activity-dependent Ca
2+-signalling is vital throughout the brain
with voltage-gated Ca
2+ entry being mediated by multimeric Ca
2+
channels [13,14]. CaV channels are grouped into three families
according to the genetic relatedness of the pore-forming a1
subunit, which confers the voltage sensitivity and conductance
specificity of the channels [15]. In mouse MNTB four high voltage
activated subtypes are expressed in maturing (P.12) principal
neurons, L-type (CaV1), P/Q-type (CaV2.1), N-type (CaV2.2) and
R-type (CaV2.3) [16] which do not contribute equally to the
whole-cell current.
Here we show that NO-dependent potentiation of CaV1 and
CaV2.1 channel amplitudes and a hyperpolarising shift of half-
activation voltages of CaV2.2 by distinct pathways underlies the
increase in whole-cell current amplitude.
Results
Nitric oxide augments whole-cell barium currents
In physiological aCSF containing 2 mM Ca
2+ we found total
ICa amplitudes in the range of 400 pA (not shown) consistent with
previous reports [16]. The use of Ba
2+ improved current resolution
as peak amplitudes of whole-cell currents increased over 2-fold in
the presence of Ba
2+ compared to Ca
2+, thus the following
experiments were performed using Ba
2+ as the charge carrier. In
order to assess nitrergic effects on CaV we applied NO-donors to
slices where residual modulation of CaV by NO was removed by
pre-incubation with the nNOS inhibitor 7-Nitroindazole (7-NI,
10 mM). Raw traces from one control cell (black trace), and two
from cells treated with the NO donors: Diethyl ammonium-
nonoate (DEA, 100 mM, green trace) and sodium nitroprusside
(SNP, 100 mM, red trace), respectively are shown in Figure 1A.
Average (mean6sem) current voltage (IV) relationships for
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32256neurons under control (7-NI-treated) and NO-donor treated
conditions are shown in Figure 1B. NO led to similar whole–cell
current potentiation induced by either donor: 7-NI control peak
amplitude was 0.9860.09 nA (n=6); DEA was 1.560.2 nA
(n=5, P,0.05) and SNP was 1.660.4 nA (n=3, P,0.05)
(Figure 1C). We did not observe any changes in inactivation rates
(t) of the total current following NO treatment: 7-NI t was
13468 ms; DEA t was 13466 ms; SNP t was 13365m s
(Figure 1D). Half-activation voltages (V1/2) which were calculated
by fitting a Boltzmann function to the normalised conductance
(G/Gmax) (Figure 1E) did not show any differences between
control and NO-donor treatment: 7-NI V1/2 was 225.561.5 mV
(n=6); DEA V1/2 was 230.462.0 mV (n=5); SNP V1/2 was
223.561.5 mV (n=3)). Overall, the data showed that treatment
of 7-NI incubated slices with the NO-donors significantly
potentiated whole-cell IBa without affecting channel inactivation
kinetics or half-activation voltages.
NO differentially modulates natively expressed CaV,
potentiating L- (CaV1) and P/Q-type (CaV2.1) currents
We next investigated how the four CaV subtypes underlying the
whole-cell current were affected by NO. Using pharmacological
tools we isolated the four CaV subtypes contributing to the whole-
cell current (Figure 2) in mouse principal MNTB neurons: L-, P/
Q-, N- and R-type. R-type current remained in all scenarios as no
specific blockers of this channel were available [17].
L+R-type and P/Q+R-type channels were isolated pharmaco-
logically by blocking N- and P/Q-type channels or L- and N-type
channels, respectively (see Methods for details). Examples of raw
control traces (black), and in the presence of NO-donor SNP
(100 mM, red) generated by a step depolarisation from 290 mV to
210 mV are shown in Figures 2Ai and Bi. Current voltage (IV)
relationships of the averaged currents (mean6sem), generated
from a voltage step protocol that included a hyperpolarising pre-
pulse to 290 mV before 5 mV step depolarisations (300 ms) to
50 mV from a holding potential of 260 mV, are shown in
Figures 2Aii and Bii. From both IVs it is clear that NO-treated
cells (red circles) produce larger currents on depolarisation than
control cells (black circles). NO exposure potentiated L+R-type
and P/Q+R-type current amplitudes without affecting channel
inactivation kinetics: L+R-type t was 179610 ms and SNP-
treated t was 214618 ms; P/Q+R-type t was 123612 ms and
SNP-treated t was 158615 ms (Figure 2Aiii and Biii). NO
exposure also had no effect on the voltage dependence of current
activation: L+R-type half-activation voltage (V1/2) was
226.561.7 mV and SNP-treated V1/2 was 226.161.3 mV; P/
Q+R-type V1/2 was 219.764.1 mV and SNP-treated V1/2 was
221.563.0 mV (Figure 2Aiv and Biv).
In contrast, when isolating N+R- and R-type channels we did
not detect any effects of NO on either amplitude or channel
inactivation kinetics. Raw traces from control and NO-treated
cells generated by a step depolarisation to 210 mV showed no
effect of NO on the isolated N+R-type and R-type currents
(Figure 2Ci and Di). The averaged IVs (mean6sem) of the isolated
N+R- and R-type channels generated by 5 mV step depolarisa-
tions (as described above) again showed no effect of NO on the
current amplitudes (Figure 2Cii and Dii), but did reveal a leftward
shift in N+R-type activation voltage. Channel inactivation kinetics
for either subtype were not affected by NO: N+R-type control t
was 158618 ms and SNP-treated t was 14669 ms; R-type
control t was 5566 ms and SNP-treated t was 74619 ms
(Figure 2Ciii and Diii). The N+R-type activation curve confirmed
the leftward shift in the voltage dependence of activation of the
channels: control V1/2 was 220.962.8 mV, whereas SNP-treated
V1/2 was 229.762.6 mV (P,0.05, Figure 2Civ). However, no
significant shift in V1/2 was observed for the isolated R-type
channels: control V1/2 was 221.763.1 mV and SNP-treated V1/2
was 228.266.0 mV. This suggests that only the voltage
dependence of activation of the N-type channels is leftward
shifted by NO.
Taken together these data demonstrate a NO-induced poten-
tiation of L- and P/Q-type currents, without affecting their
channel inactivation kinetics or half-activation voltages, and a
leftward shift in the half-activation of N-type channels, but no
effect on N-type current amplitude.
NO-dependent modulation of channel subtypes is
maintained over time
As we have previously shown that nitrergic effects can vary in
their time course [4,18] we next sought to analyse the time
dependence of NO effects on Ca
2+ channels. The averaged control
(black circles, mean6sem) and whole-cell peak current amplitudes
from unpaired recordings from slices exposed to NO over time
(red circles) are shown in Figure 3A–E. We found that the
potentiation of total whole-cell, L+R-type and P/Q+R-type
currents observed in the previous figures was maintained over
5–60 min of NO exposure (Figure 3A–C). Similarly, the null-effect
of NO on N+R- and R-type current amplitudes was also
maintained over the 60 min of NO exposure (Figure 3D, E).
Due to the lack of a temporal aspect to the NO-dependent
modulation of the currents we summarised the observed current
amplitude changes in the bar graph in Figure 3F. The bar graph
shows the potentiating effect of the pooled NO donors (100 mM
Figure 1. Nitric oxide augments whole-cell barium currents. A,
Raw traces of recorded unpaired barium currents of control (7-NI)
neurons and following exposure to NO donor (DEA or SNP, 100 mM
each) using the protocol shown above. B, Average I/V curves under
conditions indicated. C, Mean peak CaV currents (arrow in A) show NO-
dependent augmentation induced by sodium nitroprusside (SNP,
100 mM) or Diethyl ammonium-nonoate (DEA-nonoate, 100 mM), data
denote mean6SEM, unpaired observations, Student’s t-test, *P,0.05.
D, Mean inactivation kinetics (t) of currents evoked by step
depolarisation to 210 mV. E, Boltzmann fit to conductances (G/Gmax)
under conditions indicated.
doi:10.1371/journal.pone.0032256.g001
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peak IBa was 0.9860.09 nA (n=6) and NO treated was
1.5260.18 nA (n=8, t-test, P,0.001). It also shows the
potentiation of L+R- and P/Q+R-type currents by the NO donor
SNP (100 mM): L+R-type control was 0.3660.04 nA (n=5) and
was increased to 0.6460.11 nA (n=5, P,0.05); P/Q+R-type
control was 0.5560.10 nA (n=4) and was increased to
0.9460.05 nA (n=4, P,0.01). N+R- and R-type current
amplitudes were unaffected in cells treated with SNP (100 mM):
N+R-type control was 0.7060.10 nA (n=6) and N+R-type +NO
was 0.6960.08 nA (n=8); R-type control was 0.4260.08 nA
(n=8) and R-type +NO was 0.3060.13 nA (n=4, Figure 3F).
Previous data from mouse MNTB neurons [16] and also rat
cerebellar granule neurons [19] showed similar relative subtype
current contributions to whole-cell Ca
2+ currents as we reported
here. The lack of modulation of N- and R-type current amplitudes
means that L- and P/Q-type currents underlie the NO-dependent
potentiation of the whole-cell IBa. NO signalling dramatically
Figure 2. NO differentially modulates expressed CaVs, potentiating L (CaV1) and P/Q-type (CaV2.1). A-Di, Raw traces of
pharmacologically isolated currents (+R-type) in A-Ci (black trace), and the same current from cells treated with SNP (red). Traces generated by
depolarising steps from 290 mV to 210 mV (holding potential of 260 mV). Aii–Dii, Average IVs of control (black circles) and SNP-treated (red
circles) neurons. Aiii–Diii, Summary bar graph showing mean inactivation kinetics (t) of currents in control (black) and SNP-treated (red) conditions.
Aiv–Div, Mean activation curves of currents recorded from untreated (black) and SNP-treated (red) cells. Curves are fitted to conductances applying
a Boltzmann equation.
doi:10.1371/journal.pone.0032256.g002
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relative to control where N- and R-type seem to be the dominant
currents (Figure 3F).
Soluble guanylyl cyclase activity is necessary for
P/Q-type, but not L-type potentiation
We next sought to delineate the pathway by which L- and P/Q-
type channel amplitudes and N-type activation voltage depen-
dence are modulated. Cells were treated with the NO-donor in the
presence of the sGC inhibitor ODQ (1 mM) and the modulated
Cav channel subtypes were isolated pharmacologically as above.
Control traces of P/Q+R-type and L+R-type currents are shown
in Figure 4Ai, Bi (black), respectively, and in the presence of NO-
donor SNP (100 mM) together with the sGC blocker ODQ (1 mM,
red). NO-dependent potentiation of P/Q-type but not L-type
channel amplitudes was removed by ODQ (Figure 4Aii, Bii,
SNP+ODQ: L+R-type: 0.6260.06 nA (n=5, P,0.01); P/Q+R-
type: 0.7060.12 nA (n=4)); N-type current amplitudes in the
presence of SNP were not affected by ODQ (0.6760.09 nA
(n=8)). This data illustrates a differential effect of nitrergic
modulation on the recorded CaV channel subtypes. Additionally,
the NO-induced left-shift in N-type activation was removed in the
presence of ODQ (Figure 4Civ, V1/2: 222.261.3 mV), whereas
half-activation voltages of P/Q+R- and L+R-type currents were not
affected by ODQ in the presence of SNP (Figure 4Aiv, Biv; P/Q+R:
221.163.0 mV;L+R:222.262.9 mV).ThebargraphinFigure4D
summarises the effects of ODQ on NO-induced changes on CaV
channel amplitudes. ODQ had no effect on CaVchannel inactivation
kinetics of all subtypes (Figure 4Aiii–Ciii, SNP+ODQ: L+R-type t,
17167m s ;P / Q +R-type t, 109610 ms; N+R-type t,1 2 8 66 ms).
Discussion
Here we have shown that activation of the NO signalling in
mouse MNTB neurons enhanced L- and P/Q-type current but
not N- and R-type current amplitudes and this subsequently
causes a change in relative contribution of the four expressed
subtypes to the total whole-cell current following nitrergic
signalling. Intracellular Ca
2+ is critically involved in many aspects
of the neuronal ‘‘life cycle’’, including communication, plasticity,
development, differentiation, migration and cell death. Moreover,
alterations in intracellular Ca
2+ signalling pathways have been
implicated in neurological diseases, such as migraine, epilepsy,
ischemia, cerebral hemorrhage and Alzheimer’s disease [20].
Together with abnormal nitrergic signalling reported in neurode-
generative conditions [7] these findings could be inter-connected.
NO has a ubiquitous role in health and disease of the central
nervous system [7] and, perhaps not surprisingly, NO is
fundamentally involved in many physiological and pathological
aspects of Ca
2+ signalling in the neuron-glial network [8,21,22].
Ca
2+entry into principal MNTB neurons occurs primarily via
activation of postsynaptic AMPAR and NMDAR [4,23,24] but
secondarily via depolarisation-induced activation of CaV. Previ-
ously we have shown that NO can modulate postsynaptic AMPAR
and NMDAR in addition to voltage-gated K
+ channels (KV3.1,
KV2.2) [4,18,23]. This broad nitrergic action ultimately affects
postsynaptic neuronal excitability and information transmission.
Whether similar NO signalling pathways occur presynaptically to
modulate KV and CaV channels or affect transmitter recycling/
release remains to be elucidated. Importantly, all our recordings
were performed at 37uC in unpaired experimental conditions to
minimise cell dialysis thereby providing intact signalling required
Figure 3. NO-dependent modulation of channel subtypes is maintained over time. A, Peak whole-cell IBa amplitudes from unpaired
recordings, control (black , mean6SEM), SNP (red)- and DEA (green)-treated neurons. B, Peak L-type (+R-type) current amplitudes from unpaired
recordings made from control (black, mean6SEM) and SNP-treated (red) neurons. C, Peak P/Q-type (+R-type) current amplitudes from unpaired
recordings made from control (black, mean6SEM) and SNP-treated (red) neurons. D, Peak N-type (+R-type) current amplitudes from unpaired
recordings made from control (black, mean6SEM) and SNP-treated (red) neurons. E, Peak R-type current amplitudes from unpaired recordings made
from control (black, mean6SEM) and SNP-treated (red) neurons. F, Contribution of the different CaV subtypes to whole-cell currents under control
(black) and nitrergic conditions (red). R-type current was present throughout all recordings. Note the large proportional increase in L- and P/Q-type
currents following NO exposure. Data denote mean6SEM, n=number of neurons, Student’s t-test, *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0032256.g003
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physiological approach where native CaV were differentially
modulated by intact NO signalling.
Previous studies in native neurons, dissociated hair cells from
frog and rat [25,26], found that nitrergic activation reduced L-type
and whole-cell ICa in a cGMP-dependent manner suggesting that
NO regulation differs greatly between cellular systems. Different
studies in rat cultured hippocampal [27] or cortical neurons [28]
suggested a NO-mediated increase in L-type currents. N-type
currents are suppressed following activation of the classical NO/
cGMP/PKG pathway in neuroblastoma IMR32 cells due to a
reduction in single channel open probability [29]. In contrast, P/
Q-type channels, which are found throughout the brain and are
postulated to participate in transmitter release, are augmented by
NO in BHK cells [30]. Many of the differences reported above
can be accounted for by differing signalling cascades: some NO
Figure 4. Soluble Guanylyl Cyclase (sGC) activity is necessary for L- and P/Q-type potentiation. Ai–Ci, Raw traces of control L- and P/Q-
type currents (+R-type, black), and the same currents from SNP treated cells in the presence of ODQ (red). Traces generated by depolarising steps
from 290 mV to 210 mV (holding potential of 260 mV). Aii–Cii, Average IVs of control (black circles) and ODQ+SNP-treated (red circles) neurons.
Aiii–Ciii, Bar graph shows mean inactivation kinetics (t) of currents in control (black bar) and ODQ+SNP-treated (red) neurons. Aiv–Civ, Mean
activation curves of control (black) and ODQ+SNP-treated (red) neurons. Curves are fitted using a Boltzmann equation. R-type current was present
throughout all recordings. D, Summary bar graph of mean peak amplitudes of control (black) and ODQ+SNP-treated (red) conditions. Data denote
mean6SEM, n=number of neurons, Student’s t-test, **P,0.01. E, Schematic illustration showing differential NO signalling to L- (direct NO effects), P/
Q- and N- type (sGC-mediated effects) Ca
2+ channels, resulting in augmented Ca
2+ influx following nitrergic activation.
doi:10.1371/journal.pone.0032256.g004
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generate free radicals or produce peroxynitrite leading to protein
S-nitrosylation or nitrotyrosination [7]. Redox-modulation of L-
type channels has been reported in cardiac myocytes leading to
current inhibition but this effect was NO-independent and
mediated by CO [31].
As illustrated in Figure 4E, our data suggest that long-term
exposure to NO, as seen during periods of enhanced neuronal
activity leads to augmented Ca
2+ influx via L- and P/Q-type Ca
2+
channels which could have important downstream signalling
effects as various Ca
2+ channel subtypes are linked to multiple
signalling pathways leading to changes in gene expression through:
CREB (Ca
2+ response element binding protein), CaRF (the Ca
2+
response factor) and NFAT (the nuclear factor of activated T-cells)
[32,33]. Ca
2+-induced gene expression has been linked to changes
in intrinsic excitability mediated by L-type Ca
2+ channels as
reported in primary hippocampal cultures [34] or organotypic
cultures of the auditory brainstem [35], whereas N-type Ca
2+
channel activation leads to gene induction through PKA and PKC
pathways. It is important to understand how nitrergic activity
might influence these Ca
2+-dependent pathways. NO-mediated
augmentation of P/Q- and L-type channels adds to the versatile
network of nitrergic signalling between cellular systems.
Materials and Methods
Brain slices preparation
Slices were prepared from CBA/Ca mice (P13–15), which were
killed by decapitation in accordance with local animal’s and the
UK Animals (Scientific Procedures) Act 1986. All procedures were
carried out complying with the policies and regulations according
to the guidelines laid down by the MRC’s animal’s ethics and
welfare committee (University of Leicester, UK) approved under
the Home Office Project License 80/2100. Brainstem slices
containing the Superior Olivary Complex (SOC) were cut in the
transverse plane using a 7550 MM Integraslice (Campden, UK) at
200 mma t,0uC. Brain slices were incubated at 37uC in aCSF for
an hour, before being kept at room temperature prior to
experiments as described previously [36] in the presence of
10 mM 7-nitroindazole (7-NI).
Electrophysiology
Cells were visualised by an upright Eclipse E600FN Microscope
(Nikon, Japan) using 606 objective. Whole-cell voltage clamp
patch recordings were obtained from principal neurons of the
MNTB at 37uC as described previously [36]. Patches with a series
resistance .20 MV or leak current .200 pA were excluded.
Voltage clamp protocols (holding potential of 260 mV and steps
of 5 mV increments for up to 500 ms) were generated using
pClamp 10.2 software and applied by an Axopatch 200B amplifier
with a Digidata 1322A interface (Axon Instruments, Molecular
Devices, US). Data were sampled at 50 kHz and filtered at
10 kHz. Temperature was maintained using a CI7800 tempera-
ture perfusion controller and bath (Campden, UK).
CaV experiments
Current-voltage relationships (IVs) were generated by plotting
peak current against command potential. Final whole-cell access
resistance was ,20 MV and series resistance was compensated by
70% (10 ms lag). Pipette solution contained (mM): CsCl (120);
NaCl (10); TEA-Cl (10); EGTA (1); HEPES (40); Phosphocreatine
(5); Mg-ATP (2); Na-GTP (0.3); ZD7288 (0.01). External aCSF
solution contained (mM): NaCl (95); NaHCO3 (26.2); TEA-Cl
(30); BaCl2 (5); MgCl2 (1.3); KCl (2.5); glucose (10); NaH2PO4
(1.25); ascorbic acid (0.5); 7-NI (0.01). TTx (0.5 mM) was used
externally to block sodium channels. All chemicals were obtained
from Sigma, except for Ca
2+ channel blockers. All recordings were
leak subtracted offline by assessing the linear leak between 2110
and 270 mV for generating I/Vs. Raw traces are un-manipulated
other than removal of capacitance artefacts for better visualisation.
All external solutions contained blockers of synaptic inputs to
prevent any spontaneous events (mM): DNQX (10), strychnine (1),
bicuculline (10) (non-methyl derivate) and Ca
2+ channel blockers
as indicated (mM): Nifedipine (10), v-Agatoxin IVA (0.2) (Ascent
Scientific, UK), v-Conotoxin GVIA (2) (Cambridge Biosciences,
UK).
Calcium channel isolation
L-type channels were isolated pharmacologically by blocking P/
Q- and N-type channels with 2 mM v-Conotoxin GVIA and
200 nM v-Agatoxin IVA, respectively. P/Q-type channels were
isolated pharmacologically by blocking L- and N-type channels
with 10 mM Nifedipine and 2 mM v-Conotoxin GVIA, respec-
tively. N-type channels were isolated pharmacologically by
blocking L- and P/Q-type channels with 10 mM Nifedipine and
200 nM v-Agatoxin IVA, respectively. R-type channels were
pharmacologically isolated by blocking L-, P/Q- and N-type
channels with 10 mM Nifedipine, 200 nM v-Agatoxin IVA and
2 mM v-Conotoxin GVIA, respectively.
Table 1 shows the peak current data for all the CaV subtypes in
control and NO-treated conditions. Our observed whole cell IBa
obtained from our recordings=R+N+L+P/Q. However our
estimated current size based on our recording scenarios is
calculated as R+N+R+L+R+P/Q+R-3R and this=0.767 nA. If
we propagate the error (D) associated with each of the recording
scenarios by using the formula:
DIBa
2~ DNzR2 
z DLzR2 
z DP=QzR2 
z22 DR2 
DIBa~0:211
Our estimated IBa, 0.7760.21 nA falls in a similar range to our
observed 0.9860.09 nA. The table shows similar results for the
NO-treated scenarios.
Statistics and Data Analysis
Statistical analyses utilized unpaired two-tailed Student’s t-test.
*P,0.05, **P,0.01 was considered significant. All data sets were
tested for normality distributions prior to comparisons. Data
denote mean6SEM, n - number of neurons tested. Activation
Table 1. CaV Subtype contribution to whole cell current.
2NO +NO
Channel Current (nA) SEM Current (nA) SEM
R 0.422 0.079 0.303 0.129
N+R 0.702 0.100 0.694 0.081
L+R 0.356 0.037 0.641 0.107
P/Q+R 0.553 0.090 0.937 0.045
Estimated IBa 0.767 0.211 1.666 0.293
Observed IBa 0.980 0.085 1.519 0.175
doi:10.1371/journal.pone.0032256.t001
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(1+exp(V2V1/2/k) with variables Imax,V 1/2 and k (slope factor).
Inactivation data was obtained by fitting a single exponential
decay to the current recorded at 210 mV.
All fits were performed using Clampfit 10.2, Sigmaplot (Systat)
or Excel (Microsoft) with least squares minimization.
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